Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

[Research advances in molecular pathogenesis of thyroid cancer].

Aleha M, Meng QB, Yu JC, Kang WM, Cao ZJ, Tian SB.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013 Aug;35(4):382-5. doi: 10.3881/j.issn.1000-503X.2013.04.005. Review. Chinese.

2.

BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (review).

Leonardi GC, Candido S, Carbone M, Raiti F, Colaianni V, Garozzo S, Cinà D, McCubrey JA, Libra M.

Mol Med Rep. 2012 Oct;6(4):687-94. doi: 10.3892/mmr.2012.1016. Epub 2012 Aug 2. Review.

PMID:
22858857
3.

Epigenetic dysregulation in thyroid neoplasia.

Kondo T, Asa SL, Ezzat S.

Endocrinol Metab Clin North Am. 2008 Jun;37(2):389-400, ix. doi: 10.1016/j.ecl.2007.12.002. Review.

PMID:
18502333
4.

Thyroid cancer development and progression: emerging role of cancer stem cells.

Malaguarnera R, Morcavallo A, Giuliano S, Belfiore A.

Minerva Endocrinol. 2012 Jun;37(2):103-15. Review.

PMID:
22691885
5.

ENDOCRINE TUMOURS: Advances in the molecular pathogenesis of thyroid cancer: lessons from the cancer genome.

Riesco-Eizaguirre G, Santisteban P.

Eur J Endocrinol. 2016 Nov;175(5):R203-17. doi: 10.1530/EJE-16-0202. Review.

6.

Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.

Montero-Conde C, Martín-Campos JM, Lerma E, Gimenez G, Martínez-Guitarte JL, Combalía N, Montaner D, Matías-Guiu X, Dopazo J, de Leiva A, Robledo M, Mauricio D.

Oncogene. 2008 Mar 6;27(11):1554-61. Epub 2007 Sep 17.

PMID:
17873908
7.

[Genetic causes of the thyroid carcinomas].

Jindrichová S, Vlcek P, Bendlová B.

Cas Lek Cesk. 2004;143(10):664-8. Review. Czech.

PMID:
15584614
8.

Molecular pathogenesis and mechanisms of thyroid cancer.

Xing M.

Nat Rev Cancer. 2013 Mar;13(3):184-99. doi: 10.1038/nrc3431. Review.

9.

New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy.

Riesco-Eizaguirre G, Santisteban P.

Endocr Relat Cancer. 2007 Dec;14(4):957-77. Review.

10.

[BRAF gene mutation in the natural history of papillary thyroid carcinoma: diagnostic and prognostic implications].

Lopes JP, Fonseca E.

Acta Med Port. 2011 Dec;24 Suppl 4:855-68. Epub 2011 Dec 31. Review. Portuguese.

11.

Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.

Schagdarsurengin U, Gimm O, Hoang-Vu C, Dralle H, Pfeifer GP, Dammann R.

Cancer Res. 2002 Jul 1;62(13):3698-701.

12.

Genetic considerations in thyroid cancer.

Patel KN, Singh B.

Cancer Control. 2006 Apr;13(2):111-8. Review.

13.

Emerging therapies for thyroid carcinoma.

Walsh S, Prichard R, Hill AD.

Surgeon. 2012 Feb;10(1):53-8. doi: 10.1016/j.surge.2011.08.004. Epub 2011 Sep 9. Review.

PMID:
22233555
14.

Thyroid tumors: histological classification and genetic factors involved in the development of thyroid cancer.

Liska J, Altanerova V, Galbavy S, Stvrtina S, Brtko J.

Endocr Regul. 2005 Sep;39(3):73-83. Review.

PMID:
16468229
15.

Genetic alterations in differentiated thyroid cancers.

Salehian B, Liu Z.

Endocr Metab Immune Disord Drug Targets. 2009 Sep;9(3):257-68. Epub 2009 Sep 1. Review.

PMID:
19594419
16.

Ha-ras oncogene (codon 12) mutation in thyroid carcinogenesis: analysis of 60 benign and malignant thyroid tumors.

Bouras M, Parvaz P, Berger N, Paulin C, Revol A.

Ann Biol Clin (Paris). 1995;53(10-11):549-55.

PMID:
8787281
17.

DNA methylation of RUNX3 in papillary thyroid cancer.

Ko HJ, Kim BY, Jung CH, Chun SW, Mok JO, Kim YJ, Park HK, Kim CH, Kim SJ, Byun DW, Suh KI, Yoo MH, Kang SG.

Korean J Intern Med. 2012 Dec;27(4):407-10. doi: 10.3904/kjim.2012.27.4.407. Epub 2012 Nov 27.

18.

Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma.

Li JY, Han C, Zheng LL, Guo MZ.

Chin Med J (Engl). 2012 Oct;125(19):3526-31.

PMID:
23044318
19.

MicroRNAs miR-146-5p and let-7f as prognostic tools for aggressive papillary thyroid carcinoma: a case report.

Geraldo MV, Fuziwara CS, Friguglieti CU, Costa RB, Kulcsar MA, Yamashita AS, Kimura ET.

Arq Bras Endocrinol Metabol. 2012 Nov;56(8):552-7.

20.

Viral mediated gene therapy for the management of metastatic thyroid carcinoma.

DeGroot LJ, Zhang R.

Curr Drug Targets Immune Endocr Metabol Disord. 2004 Sep;4(3):235-44. Review.

PMID:
15379725

Supplemental Content

Support Center